News

Low BMD Seen In Many Elderly Black Women


 

RIO GRANDE, P.R. — Approximately one in four elderly black women have osteoporosis, findings from a small study suggest.

Physicians should not ignore the possibility of osteoporosis in their older black female patients, although these women are not usually considered at high risk, compared with other demographic groups, said Dr. Sally P. Weaver, of the McLennan County Medical Education and Research Foundation, Waco, Tex.

Previous studies of osteoporosis in women have focused mainly on white women because of evidence of an elevated risk for osteoporosis in that population. Yet older women of any ethnicity are prone to age-related fractures if their bone mineral density (BMD) is low, she said in an interview.

Dr. Weaver and her colleagues measured BMD scans from the electronic health records of 44 black women aged 70 years and older. Patients with conditions that could affect bone turnover, vitamin D absorption, or calcium absorption were excluded from the study.

About 50% of the study participants met the criteria for osteopenia and 10% met the criteria for osteoporosis at the left femoral neck. Approximately 25% met criteria for osteopenia or osteoporosis at the lumbar spine. Overall, the left femoral neck had the lowest regional BMD. Dr. Weaver presented the results in a poster at the annual meeting of the North American Primary Care Research Group.

Dr. Weaver had no financial conflicts to disclose.

Recommended Reading

Declining BMD Found to Raise Cardiovascular Risk
MDedge Endocrinology
PTH Response May Explain Higher BMD in Blacks
MDedge Endocrinology
Fish Oil, Multivitamin Gave Same Vitamin D Boost
MDedge Endocrinology
Hip Fracture Risk Higher in Elderly With Diabetes
MDedge Endocrinology
Vitamin D for Breast-Feeding Moms Benefits Infants
MDedge Endocrinology
Denosumab May Suppress Bone Turnover in Ca
MDedge Endocrinology
Low BMD Linked To Myocardial Ischemia Risk
MDedge Endocrinology
PPI Use Linked to Slight Rise in Hip Fracture Risk
MDedge Endocrinology
Obese Patients May Not Be Safe From Osteoporosis After All
MDedge Endocrinology
After 5 Years of Alendronate, 5 More Years Show Little Benefit
MDedge Endocrinology